YB-1, or Y-box binding protein 1, is a multifunctional protein that plays crucial roles in various cellular processes, including transcriptional regulation, mRNA splicing, and DNA repair. YB-1 belongs to the cold shock domain protein family, which is characterized by a nucleic acid-binding motif. As a pivotal protein, YB-1's activity can be modulated by various post-translational modifications and interactions with other proteins. YB-1 activators are molecules that stimulate or enhance the activity of the YB-1 protein. Their ability to modify YB-1's function can lead to profound changes in cellular dynamics, impacting how genes are expressed and how the cell responds to various environmental cues.
The specificity of YB-1 activators can vary, and they can act through various mechanisms. Some may bind directly to YB-1, altering its conformation and thus its binding affinity to its targets. Others might influence the post-translational modifications of YB-1, such as phosphorylation, which can in turn modulate its activity. There are also activators that may not interact with YB-1 directly but instead affect its upstream signaling pathways, resulting in an enhancement of YB-1's function. The specificity and selectivity of these activators are essential, as off-target effects can lead to unintended cellular outcomes. As research progresses, understanding the detailed mechanisms and potential selectivity of these activators becomes crucial, especially when considering their impact on complex cellular networks and systems.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin may increase YB-1 expression, which is linked to chemotherapy resistance in certain cancers. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin treatment has been shown to elevate YB-1 levels, possibly aiding in DNA repair mechanisms. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D can stimulate YB-1 nuclear translocation, potentially affecting gene transcription. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide may upregulate YB-1, impacting DNA topoisomerase II activity and cell cycle progression. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $112.00 $394.00 | 8 | |
Oxaliplatin can increase YB-1 expression, potentially influencing DNA repair pathways. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel has been linked to enhanced YB-1 expression, possibly affecting cell division. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil may induce YB-1 expression, possibly playing a role in RNA metabolism and function. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate can increase YB-1 levels, potentially affecting cell proliferation and apoptosis. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea may lead to elevated YB-1, influencing DNA synthesis and cell cycle checkpoints. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Gemcitabine may boost YB-1 expression, potentially playing a role in nucleotide metabolism. | ||||||